Pulmatrix Inc (PULM): "We reached a major milestone in the fir...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	511
Posts	59400
Boards Moderated	4
Alias Born	12/21/2009

hedge_fun

Re: deadjim post# 2459

Wednesday, 05/15/2019 11:50:56 AM

Wednesday, May 15, 2019 11:50:56 AM

"We reached a major milestone in the first quarter with the FDA providing approval to begin our planned Pulmazole Phase 2 clinical trial. With the closing of our recent financing in April and receipt of the upfront payment from Cipla related to the Definitive Agreement for the co-development and commercialization of Pulmazole, we currently have a cash balance of approximately $37 million which fully funds Pulmatrix beyond the completion of the Phase 2 trial that will begin this quarter," said Robert W. Clarke, Ph.D., chief executive officer of Pulmatrix.

https://ih.advfn.com/stock-market/NASDAQ/pulmatrix-inc-PULM/stock-news/79920689/pulmatrix-reports-q1-2019-results

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent PULM News

Form 8-K - Current report • Edgar (US Regulatory) • 03/04/2024 09:06:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 02:00:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 02:20:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 02:05:40 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 01:20:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 01:05:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 08:05:12 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 01:05:21 PM